Adlai Nortye Group Ltd. (ANL) stock
ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.03−0.58 (-5.47%)
Close on Nov 16, 2026Market cap $401.20MP/E –Yield –
Adlai Nortye ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was -$35.22M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$35.22M | – |
| FY2024 | Dec 31, 2024 | -$52.42M | – |
| FY2023 | Dec 31, 2023 | -$72.09M | – |
| FY2022 | Dec 31, 2022 | -$66.66M | – |
See a number that looks wrong?